Table Of Content

Author index 1457 Collett JA 1032 Fan ST El81 Gunawan ES 752 Collins E 175 Fan Y-F 519 Gupta A 211,771 Conrad A 945 Faoagali ] 952 Gupta SC 737 Cook HB 1032 Farrell GC i, E1, E126, 815,1093 Gupta SD 473, 1318 Cooper JE 807 Farthing M]G G38 Core Working Party for Asia-Pacific Farztdinov KM 1243 Haber GB G86 Consensus on Hepatitis B and C Feng L 1272 Haga H 1079 825 Fevery ] 842 Hall ]C 706 Correll PKL E83 Field A 99 Hamaguchi S 617 CossartYE 175 Field AF 730 HanJY 1393 Cotton PB G34 Figler M 105 Hananoki M 121 Coudray-Lucas C 1199 Findlay M 725 Hanazaki K 327 Crabtree] 1370 Fock K-M G58, 230, 494, Hannoun L 1199 Craig JR 945 622,1089 Hansky ] 35 Cronin V 192 Fook-Chong SMC 895 Hao L-] 1165 Crotty B 762 Forbes DA 53 Hara ] 1400 Crowe] 1028 Forbes GM 1223 Harada Y 1442 Cullen D] 457 Frampton CMA 1032 HardikarW 1100 Cullingford GL 457 Fraser R 1132 Haruma K 121, 277, 766, 1022 Cuomo O 654 Freiman ]S 227 Hasegawa A 271 Cynober L 1199 Frisby C 1132 HashikuraY El 75 Fromm H 239 Hashimoto N 257 D’Amico RA 783 FuX-X 1165 Hashizume M 142 Dai C-Y 792, 1404 Fuji! S 1277 Hasnian SS 1356 Dai D-I 182 Fujimori S 1272 Hata] 121,1022 Dai S 148 Fujimori T 1151,1277 Hatano R 786 Dakic B 254 Fujimoto ] D33 Hato F 1400 Daschner A 503 FujiokaT D55 HayakumoT 1333 Davaris PS 369 Fujisawa T 632 Hayashi N 507, 1312 de la M Hall P 1307 Fujita M 1277 HayashiY 422 De BK 412 Fujiwara M 443 Hegar B 593, 902 de Medina M 945 Fujiyama Y 61, 215, 688 Hellard ME 290 Dejong T 1386 Fukuda H 786, 1432 Herrerias-Esteban ]M 567 Demmler K 1325 Fukuda K 931 Herrerias-Gutierrez ]M 567 Desmond P El23, 865 Fukuda S 906, 1370 Higuchi K 215, 849 Dhang DK 1037 Fukuda T 215 Hirose M D20 Di Matteo AC 1362 Fukui H 1151,1277 Hirota K 155 Dilavvari ]B 26 FukuzawaY 431 Hogg GG 290 Dong S-H 512 Fulcher DA 344 Holloway R 1362 Dono K 1447 Furuya S 880 Honda S D55 Doong M-L 1120 HongW-S 1037 Dore G] E83 Galasso G 326 Hopper ]L 939 Dow R 1257 Gane E El87 HoriM 381,752 Dowling D] 939 Garas G 1223,1348 Horiike N 632, 1054 Duggan A 1 Gejyo F 257 Horita K 565 Duggan ]M 1 George ] 819 Horiuchi A 220 Duseja A 26 Ger L-P 284 HoshinoT 1272 Dutta U 822 GeubelAP 1232 Hosokawa M 931 Dwivedi M 737 Gibikote SV 454 Hotta K 45 Gibson PR 192, 626 Howard ML 865 Eapen CP 454 Giltinan D 555 Howarth G 1132 Ebara M 786, 1432 Gionchetti P 489 Hozawa S D26 Edgar C 300 Goh K-L G58, 230, 910 Hsieh]-F 1059 Edmunds SE] 1348 Gomez AA 503 HsiehM-Y 417,792 Eguchi H 1447 Goto M D20 HsiehY-H 684 Elias E 570 Goto S 1064 Hsu ]-H 536 Endo H 1113 Gotoh M 1447 Hsu P-I 284, 536 Endo K 1344 Gow'ans E] 952 HuWHC 470,1251 Endo M 1344 Graham D 1353 Huang DY 1176 Enomoto N D20 Grant] 192 Huang W-K 284 Eto S 1442 Grossini E 1411 HuangfuY-S 1165 Guan R E34, 1356 Hubscher SG 570 Fairley CK 290 Guardascione MA 654 Huprich ]E 1221 1458 Author index Hwang S-J 95, 1171 Kalia N 133,915 Kishimoto M 381 Hyland CA 952 Kamada T 277 Kishimoto S 277 Hyogo H 887 Kamiya S 168, 374 Kishimoto S-I 1447 Kanaji K 617 KitadaiY 766 IchibaT 331, 402, 542, 647, 1205, Kanamaru T 422 Kitagawa S 1400 1212, 1292 Kanda M 1105 Kitajima M 507 lerna D 783 Kanda T 1048 Kitamura T D20, 640 lida M 381 Kaneko E 271 Kitano A 1400 lijima A 311 Kaneto H 381 Kitano S 1064 lijima H 752 Kang L-J 925 Kitaoka A 617 Ikeda M 381 KaoJ-H E91, 391, 1287, 1418 KiyoharaT 1125 IkegamiT El75, 443 Karasawa T 1079 Kiyosawa K E97, 220, 311, 1292 Ikejima K D20 Kashida H D66 Kobayashi F 1382 IlanY 1436 Kashima K 294 Kobayashi H 461 IlsleyAH 1307 Kashimura H 744 Kobayashi M 311, 1272 Imazeki F 1048 Kashiwagi S 1377 Koda M 1424 InabaY 1382 KatayevVA 1243 Kodama M 931 Inao R 617 Katelaris PH 386 KogaY 168,374 Inoue F 461 Katkhouda N 1221 Kohgo Y 680 Inoue G 1054 Kato T 647 KohliY 161, 257 Inoue M 277 Katoh M 542 Koide N 69, 327 IpKS 1100 Kaur U 26, 550 Kolivas S 1257 Irving M G26 Kaushik SP 563 Komatsu T 1312 Ishibashi T 1382 Kawa S 220 KondoF 786, 1229 Ishihara S D7 Kawabata H 127 KondoY 40, 880 Ishii H D46, 695 Kawaguchi H 277 Kong S-E 706 Ishii R 1079 Kawai K 1333 Kono H D20 IshikawaT 402,431,647 Kawai N 752 Korah IP 454 IshikawaY 507 Kawai S 1048 Korman MG 21, 35 Islam S 809 Kawamata H 1113,1277 Koyama S 688 Isobe K 529 Kawano S Dl, 752 Krawczynski K 9 Itabashi M 744 Kawasaki H 1424 Kubosawa H 880 Ito H 880 Kawasaki S El75 Kubota T 507 Ito S 40, 161, 257,431 Kawauchi S 37 KubukiY 83 ItoY 161,257 Kazykhanov NS 1243 Kudo S-E D66 Itoh H 76, 422 Ke M 230 Kullavanijaya P G58 Itoh S 443 Kew M 357 Kumagai H 1344 Itoh T 422 Khasanov RSH 1243 Kumai K 507 Iwamoto S 678, 808, 1219 Khor C 622 Kunikata T D37 Izawa T 680 Khor CJL 494 Kuriyama M 161, 257 Khusnutdinov SM 1243 Kuroda N 1192 Jacobs 133,915 Kiba T 640 Kuroda Y 422 Jaeschke H 718 Kido S 766 KurokiT 215, 1400 Jayaraj AP 610 Kikuchi S 271, 1382 Kurosawa M 271, 1382 Jeffrey GP 665 Kim B-H 512 Kurukawa H 577 JiaDM 1183 Kim H-J 512 KusakaT 1151,1277 Jia L 148 Kim HY 1037 Kusunoki H 1022 Jie R 1257 Kim JH 1043 Kwok K-F 453 Jimenez-Saenz M 567 KimJS 1043 Kwon OS 1043 JinnoY 1400 Kim PS 1393 Kwon SY 1282 Jones DB 386 KimTS 1393 JooY-S 512 KimW-H 512 Lai CL 1251 Joshi BL 202 KimY-B 1393 Lai C-L E20 Jung SA 1037 KimYK 1037 Lai KC 1251 Kimber RD 959 Lai K-H 284, 536 Kabir AMA 374 Kimura A 752 Lai M-Y E130, 391, 1287, 1418 KajimotoY 381 Kimura F 76 Lai OF 895 Kajinami T 61 Kimura K G58 Lam SK i, 1007, 1251 Kajiyama G 121, 277,766,887, Kimura T 443 Lam S-K 230, 470 1022 Kinoshita Y D7 Lambert JR 254 KakiuchiY 752 Kirsch R 1298 Lamers CBHW 498 Kakumu S 431 Kirsch RE 1298 Lan K-H 1171 Kaldor JM E83 KishidaT 1272 Langman J 1132 Author index 1459 LattNC 175 Maity AK 412 Miyamoto A 1447 Lau CS G58 Malcontenti-Wilson C 1386 Miyano S 1079 LauGKK E46, 1251 Malki S 962 Miyashita M 69 Lau JYW G8 iMarks RD 213 Miyazaki A D20 Le Leu RK 1158 Maruyama K D26 Miyazaki H 647 Lee CH 1043 Masel SL 457 Miyazaki M 76, 529, 880 Lee C-M 1064 Mashford ML 865 Miyazaki Y 1125 Lee DK 1037 Masuda T 1344 Miyazawa S 45 LeeJ-1 512 Mathaba LT 53 Miyoshi A 277 Lee K 555 Mathiina PM 1028 Mizoguchi H D37 Lee S-C 284 Matsuda H 61 Mizokami M 311 Lee S-D G94, 95, 284, 684, 925^ Matsuda K 127 Mizukami Y 680 1120, 1171 Matsuda Y 402, 647 Mizukoshi H 271 Lee S-H 512 Matsuhisa M 381 MizumotoT 461 LeeWM 480 Matsui S 1205 Mizuno M 331 LeeYM 622 Matsumata T 320 Mochizuki T 604 LeiH-Y 519 Matsumoto T 1400 Monden M 1447 Lesmana L 1356 MatsunagaY 327 Moreno-Ancillo A 503 Leung JW G73 Matsuo N D98 Morgan EH 665 LeungN E53, 1356 Matsuo T 1079 Mori M 1138 Lewin MR 610 Matsuoka H 83 Morimoto H 1442 Li C-P 95, 684 Matsushita K 1192 Morimoto I 1442 Li D 1145 Matsushita R 83 Morimoto M 294, 640 LiL 1176 Matsuzaki Y 443 MoritaK 640,1277 LiY 148 MatsuzawaY 1125 MoritaY 422 LiYQ 865 McCaughan GW El72, G90, 175. Mosca S 326, 654 LiawY-F El, E31, 182, 815 227, 467,815 Motoi M 331 Lidiums I 1341 McCauley R 706 Mouri H 69 Liew K 563 McDonald JA 809 Mozsik G 105 Lin BPC 386 McHutchison JG 581,945 iMukai H 1333 Lin C-K 284 McIntosh GH 1158 Mukawa K 220 Lin C-P 536 Mehrotra P 771 Mulagha E 239 Lin P-W 519 Members of the Swedish Internal Mulder RT 300 Lin S 254 Medicine Liver Club (SILK) 437 Miiller-Myhsok B 771 LinW-Y 1059 Mercer JF 1325 Munakata A 906,1370 LinX-Z 1071 Merican I E71, 1356 Murawaki Y 1424 LinY-C 1064 Meshram M 1018 Murayama H 1105 Lin Z-Y 417, 792 Michitaka K 632, 1054 MurayamaY 1125 Lindgren S 437 Midolo PD 254 Muto H 744 Liu C-J 391,1287 Migoh S 142 Lo CM El81 MikamiT 1370 Nada T 40 Lo G-H 284,536 Miki K 271 Nagano H 1447 Lo S-Y 182 Militerno G 654 Nain CK 550 Locarnini S G46, 304 Milkiewicz P 570 Nair A 454 Loffeld RJLF 498 Mimura H 263 Nakagawa K 76 Lonardo A 775 MinYI 1037 Nakagawa Y 294 Longkumer T 1318 MinamiT 1125 Nakahara A 744 Lopez-Serrano C 503 Mine S 1442 Nakai T 529 Lord RVN 730, 1221 Misajon A 1386 Nakajima M 1333 Louw J G58 Mison LM 952 Nakajima N 880 Lu C-C 519 Misra S 737 Nakajo S 294 Lu C-L 925 MisraV 737, Nakamori S 1447 Lu R-H 925,1171 MitaA El 75 Nakamura H 931 Luo J-C 95 MitaY 431 Nakamura N 220 Mitsuhashi H 1079 Nakamura S 1400 Macdonald GA 980, 992 Miwa H D60, 967 Nakamura T 263 Machin D 725 MiwaT 168,374 Nakano Y 680 Mackay IR 3 Miyagawa J-I 1125 Nakashima T 294 Macrae FA 939 Miyagawa S-I El75 Nakasho K 1192 Madesh M 109 Miyaji H 161, 257 Nakaya Y 40 Maeda K 1105 Miyajima H 40 NakazawaY El 75 MaedaS 155,1192 Miyake K 1377 N arayanan TS 1018 Maharajan KG 202 Miyake M 529 Narisawa R 604 1460 Author index Nassberger L 437 Omata M E134, E141, 155 Rokuhara A 1292 Nathanson LK 871 OnjiM 632,1054 Rokutan K D12 Neri S 783 Onomura M 931 Rosella O 626 Nestel PJ 871 Orii K 1292 Rosmawati M 910 Nevens F 842 Osaki T 374 Ross A 300 Ng KCK 453 Oshitani N 1400 Rui J-A 422 NgTM 494,622 Ossowicz CJ 1307 Rumi G 105 Ngu MC 386 Ostapowicz G 480 Russell EG 254 Nicholson FB 21 OtaniY 507 Russell RI G58 Nicholson L 254 Otsuki M 071,1183 Ryan E 1028 Nicoll A 304 Nicosia G 1411 Pai CG 30 Safary A 396 NieY 148 Pan H-B 536 Saigenji K 45 Nijevitch AA 1243 Panda SK 473 Saijyo T 40 Nilsson S 437 Papaparaskevas I 369 Saisho H 786, 1048 NishiawaY 1292 Parasakthi N 910 Sait H 695 Nishida O 461 Park E-B 1037 Saito H 680,1370 Nishioka M 127,1176 Park GJ-H 386 Saito K 40, 1079 Nishiya D 906 Park H 294 Saito S 640 Noda M 529 Park H-J 230 Saito T 565, 1079 Nomura F 529 ParkSH 1043 Saitoh T 604 Nomura H 1377 Patel C 1318 Sakaguchi K 69 Nomura M 40 Patella S 798 Sakai T 1333 Nozawa S 880 Paulus B 1145 Sakamoto C 1272,1277 Nozoe T 320 Pavli P 962 Sakamoto T 1138 Numata K 640 Pawarode A 860 Sakata T 331 Paxman AE 53 Sa’Kon M 1447 O’Brien PE 1386 Peach HG 1267 Saksena S 570 O’Grady R 730 Peduto AJ 980,992 Sakurai Y 680 O ’ KeaneJC 1028 Peng N-J 284 Salas E 567 Oates PS 665 PhietPH 1356 Samal SC 454 Obara T 680 Pianko S 581, 798 Samman MA 325 Obata H 294 Picciotto FP 654 Sanefuji H 1442 OchiaiT 83 Pihar A 567 Sano T 1113 Ogawa S 69 Platell C 706 SanoY 1151 Ogihara A 271 Plummer JL 1307 Sarin SK El64 Ogoshi K G82 Poidinger M 952 Sartori M 1411 Ogura K 155 Poupon R 1199 Saruya S-Y 1138 Ohara S 45 Praga Pillay S 871 Sasahara K 127 Ohgami M 507 Prentice DA 865 Sasaki M 688 Ohkawa J 744 Sasaki T 294 Ohkuma K 1105 Ragozzino A 326 Sasaki Y 155,752 Ohsumi K 617 Rains N 698 Sasson O 1436 Ohta-Tada U 374 Ramachandran A 109 SataevVU 1243 Ohtsuka M 880 Ranjeev CK 910 Satchithanantham S 895 Ohya M 931 Ratnaike S 192 SatoJ 1272 Oide H D20 Rebollo J 567 Sato K 542, 1202 Oikawa H 1344 Reed MWR 133,915 Sato N i, D20, D60, 967 Okabe N 1105 Reyes R 1325 Satoh H 542 Okada M 1105 RheeJC 1037 Satoh T 402 Okada S 346, 965 Rhee P-L 1037 Saunders JB 175 Okamoto E 1022, 1192 Richardson MA 21 Sawa Y 1400 Okamoto M 461 Rigamonti C 1411 SawahataT 744 Okamoto S 277 Riordan SM G17 Sawaoka H 752 Okamura S-I 1138 Riottot M 871 Sawayama T 69 Okanoue T 294 Ritz MA 1362 Saxena A 473 Okazaki I 26 Rivera CA D20 Schemmer P D20 Okazaki R 263 Rizzello F 489 Schiff ER 945 OkiY 1113 Ro S 263 Schirmer M 1132 Okolicsanyi L 244 Roach PD 871 Schlemper RJ G49 Okuda K 91, 808, 957, 1078, 1219, Roberts-Thomson IC 93, 213, 677, See SJ 622 1339 807,959,1077,1341 SeinoY 931 Omari TI 1362 Rojas M 567 Seki S 1400 Author index 1461 Sekihara H 640 Stace N E79 Tanaka Y D98 Seko S 461 Stanton R 35 Tandon RK G69, G78 Sempoux CL 1232 Stevens IF 300 Tang J-H 182 Sen S 412 Strazzabosco M 244 Tang Z-Y G1 Seo M 1105 Stubbs RS 698 Tangkijvanich P 860 ShaW 148 Su C-X 1165 TaniH 1022 Shackel NA 467 Sul-J 519 TaniguchiT 461 Shah SK 1018 Suarez de Parga J 503 Tanikawa K 579 Shanmuganathan G 1362 SugaT 220,604,1205 Tanoue K 142 Shannon C 99 Sugahara S 542, 1202 Tashima K D37 Sharma TR 26 Sugimachi K 142, 320 Tatsuguchi A 1272 She Q 148 Sugimachi M 1125 TatsumaT 1064 Sheehan C 730 Sugimoto H 257 Tazuma S 887 Shephard EG 1298 Sugitani S 647, 1205 Teo E-K 494 Shiba M 215 Sugiura M 786 Teo EK 622 ShibataY 1272 SugiuraT 76 Terada M 175 Shiesh S-C 1071 Sugiyama M 402, 647 Terasaki T 327 Shima T 294 SugiyamaT 1377 The Consensus Interferon Study Shimamura T D98, 640 Sumii K 121, 277, 766, 1022 Group 945 Shimizu H D20, 76, 880 Sun HS 1356 Thomas C 665 Shimizu 1 D84 SunW-H 752 Thomas RJ 697 Shimizu Y 849, 880 Sung JJY G58 Thurman RG D20 ShimoyamaT 906, 1370 Sung M-H 792, 1404 Tian G-S 1165 ShinodaT 76 Suto H 161,257 Toda G E117 ShinomuraY 1125 Suto T 906 Togashi H 1079 Shinozawa 1 1272 Suwa T 76 Togaw'a A 529 Shinzawa H 1079 Suzuki H D46 Tokieda M D55 Shiohara E 327 Suzuki K 744 Tokuka A 617 Shiojima J 263 Suzuki M 83 Tokunaga Y 617 Shiraga K 69 Suzuki N 215 Tokushige K 1312 Shirahase H 617 Suzuki S 422 Tominaga K 215 Shiraki K Ell Tomoda J 331 ShiratoriY E134, E141, 155 Tomono H 263 Shoda J 443 Tabaru A 1183 Tong MJ 95, 945 Shrestha S 202 Tada H 294 Tovey FI 610 Shrestha SM 202 Tada M D98 Trande P 775 Shu D 1000 TagayaT 431 Treepongkaruna S 555 Shudo R 565 TakagiA 168,374 Triadiafalopulos G G58 ShulkesA 1257 Takahashi K 565 Tsai C-C 284 Shyamkumar NK 454 TakahashiT 1079,1205 TsaiJ-F 417,792 Sievert W 798 Takaishi O 215 Tsai R-J 1287 Sinclair A 626 Takaki A 69 Tsai S-C 1059 Sinclair MI 290 Takano T 1344 Tsao H-C 1071 Singh K 550 Takasaki K 1312 Tsay D-G 284 Singh RP 26 Takata M 1192 Tsay SH 95 Singh UA 737 TakedaY 1079 Tseng H-H 284,536 Singh V 550 Takei Y D20 Tsubouchi H 83 Sinha SK 550 Takenaka R 331 Tsuga K 121,263 Sjalfoellah Noer HM 1356 Takeuchi K D37 Tsugawa K 142 Skinner SA 1386 Tam W 677 Tsuji S Dl, 752 Smallwood R 304 Tamegai M 461 TsujiT 69,331 Smallwood RA 762 Tamura T D66 Tsujii M 752 Smith JL 871 Tan AL 494 TsujikawaT 688 SobolT 1436 Tan CK 725 TsujinoT 381 Sollano J G58, 1356 Tan KC El78 Tsukada H 931 SomaY 1370 Tan S 895 TsukadaY 604 Song IC 895 TanYM 910 TsukishiroT 849 Song IS 1037 Tanaka E E97, 311, 1292 Tuen H 453 Soo KC 895 Tanaka K 640 Turner JH 457 Sougioultzis S 369 Tanaka M 1370 Tytgat GNJ G30 Spencer JD 175 Tanaka N 443, 744 Tzivras M 369 Spirli C 244 Tanaka S 1272 St John DJB 939 TanakaT 1192 Uchida M 542, 1212 1462 Author index UchidaT 215 Watanabe S 168, 374 Yamashita K 83 UchidaY 127 Watanabe T D26, 45, 215, 744 Yamashita Y 1138 UedaY 1151,1277 Watarai T 381 Yamauchi K 1312 Uehara K 542 Werdmuller BFM 498 YamazakiY 161, 257 Uematsu K 1192 Wheeler NSJ 325 YangS-K 512,1037 Umeda S 215 Whibley C 1307 Yano M E111 Umegaki N 906 Whitehead MR 1032 YaoG-B E61, 1165 Umeshita K 1447 Whitehead RH 1325 Yasuda K 1333 Uno K 1333 Wieslander J 437 Yasui C 1192 Uotno G 326 Williams R G17 Yasumaru M 752 Urabe M 688 Williamson R 1325 Yatsuhashi H E111 UrakamiY 1113 Wilson I 1145 Yeh C-T 182, 339 UshijimaT 61 Wittenberg LN 871 Yen S-H 684 WongBCY 1007,1251 Yeoh E 1132 van der Putten ABMM 498 Wong C 725 Yeomans N G58 Vandemaele K 902 Wong J 453 Yeon JE 1043 Vandenplas Y 593, 902 WongKW 1251 Yi SY 661 Venturi A 489 WongWM 1251 Yokosuka O D91, E41, 1048 Verbaan H 437 Woodburne VE 1298 Yonekura K 402, 542, 1202 Verma S 550 Wu H 148 Yonezawa M 1272 Vickers C 99 WuJ-C 1171 Yoo HM 1037 Viranuvatti V 1431 YooJY 1037 Vogiagis D 1386 Yoshida H 155 Xiao SD G58 Voravud N 860 YoshidaY 1272, 1370 Xu D-Z 1165 Yoshihara M 277, 766 Xu DZ 1356 Wada N 507 Yoshikau'a M 786 Waku K 565 Yoshioka K 431 Wang B-E E67 Yachha SK 771 Yoshizawa K 1292 Wang C-S 1404 Yagi S 311 Young D 698 Wang L-Y E3, 792, 417, 1404 Yagi T 617 Young GP 1158 Wang PS 1120 Yaguchi M 529 Yu M-L 417, 792, 1404 WangW 422 Yakabi K 263 Yu M-W E3 WangWH 1007 Yamada S 1442 YuW 148 WangY-J 1171 Yamagiwa S 542, 1202 YuWK 895 WangY-Y 536 Yamaguchi K D98 Yuen ME 1251 Ward PB 53 Yamamoto E 617 Yuen M-F E20 Ward R 99 Yamamoto M 422 Yukawa M 786 Ward RL 730 Yamanaka J 1192 Yukinaka M 40 Warmington JR 53 Yamanaka N 1192 Watanabe A 849, 969 Yamasaki Y 381 Zeniya M El 17, 342 Watanabe H 766, 1079 Yamashina S D20 Zhou L 422 Journal of Gastroenterology and Hepatology (2000) 15, 1463-1480 Subject Index to Volume 15 Abstracts Inaugural Scientific Symposium of the Centre of Alimentary Research and Education in Conjunction with ‘Controversies in Gastrointestinal Pharmacology’: International Union of Pharmacology A1 11 th Asian Pacific Congress of Gastroenterology, 8th Asian Pacific Congress of Digestive Endoscopy, March 10-14, 2000, Hong Kong, China B1 lASL-APASL Joint Meeting 2000, 2-7 June 2000, Fukuoka, Japan El The Third Western Pacific Helicobacter Congress, 21-24 June 2000, Denpasar, Bali, Indonesia HI Liver Diseases in the New Millennium, 23-26 September 2000, Shanghai, China II Australian Gastroenterology Week 2000, 18-21 October 2000, Hobart, Australia J1 Supplements Selected Reviews in Gastroenterology and Hepatology for the New Millennium D1 Towards Consensus on Prevention and Management of Hepatitis B and C in the Asia-Pacific Region, 6-7 September 1999, Kyoto, Japan El 11 th Asia Pacific Congress of Gastroenterology, 8th Asian Pacific Congress of Digestive Endoscopy, Conference Proceedings, 10-14 March 2000, Hong Kong, China G1 abdominal pain; a man with (Images of Interest) 1078 alfacon-1 compared with a-2a-IFN in Chinese patients aberrant crypt; NS AID with different cyclo-oxygenase with chronic hepatitis C 1165 inhibitory profiles that prevent foci formation but vary in selection for IFN treatment of hepatitis C E117 acute gastrotoxicity in a rat model 1385 consensus on management of El26 ablation therapy; a man who underwent local, for HCC detection of hepatitis A viral RNA in sera of patients with (Images of Interest) 808 acute HAV 1043 accuflex stent; temporary use for unextractable common bile interferon monotherapy in chronic hepatitis B E34 duct stones (Case Report) 680 in drug-using women before and during pregnancy 175 achalasia; botulinum toxin for, in children 1100 natural history of HCV infection 105 acid secretion; regulatory mechanism of, in the damaged nucleoside analogues in the treatment of chronic stomach, role of endogenous nitric oxide D37 hepatitis B E53 adenocarcinoma predictors of the efficacy of IFN therapy for patients with K-ra5 codon 12 mutations in Barrett’s oesophagus 730 chronic HCV before and during therapy: how does this oesophageal; understanding the molecular changes in modify the treatment course? E141 Barrett’s oesophagus (Editorial) 697 ratio with AST in chronic HCV, useful cirrhosis predictor pancreatic 386 cancer G13 treatment of chronic ductal; clinical significance of cathepsin E in pancreatic HBV infection: who, when, what for and how E31 juice in the diagnosis of 1333 hepatitis B in Australian and New Zealand E79 adenoma alcoholic liver disease; impact of alcohol on Kupffer cell diagnostic criteria for gastrointestinal carcinomas in ability to produce chemokines (Review) 349 Japan and Western countries, proposal for a new alpha-fetoprotein classification system of gastrointestinal epithelial clinicopathological analysis of stage II-III HCC showing neoplasia G49 early massive recurrence after liver resection 1192 flat; early colorectal cancer, flat or depressed type D66 parathyroid hormone-related peptide producing hepatic resection of benign liver tumours (Review) 587 cholangiocellular carcinoma with a marked psammoma adenosine diphosphate-ribosylation; enhancement of, in formation (Case Report) 1442 human HCC 529 spontaneous regression of HCC (Editorial) 965 adenosine triphosphate agglutination test, latex; measurement of eradication of H. measurement of, in NSAID 127 pylori infection 254 dependent energy systems; and tissue hypoxia in humans alpha-interferon (Editorial) 105 sustained response to combination therapy in a patient ADP see adenosine diphosphate with chronic HCC and (Case Report) 567 AFP see alpha-fetoprotein treatment; response of chronic HCV patients, hepatic AHF see acute hepatic failure histological improvement as a total bile acid serum level alanine aminotransferase indicator 294 a multicentre, randomized, controlled trial of IFN ALT see alanine aminotransferase 1464 Subject index amino acid, branched chain; applications for and nutritional epidemiology of HBV infection in the E3 supplement benefits (Review) 706 public health measures to control HBV infection in the amoxycillin developing countries of the E7 clarithromycin resistance in H. pylori infection survey of gastrointestinal endoscope disinfection and (Editorial) 1089 accessory reprocessing practices in the G78 H. pylori infection in childhood, results of management the role of JGH in gastroenterology i with ranitidine bismuth citrate, tinidazole and 1243 towards consensus on the control of chronic hepatitis B anaesthetic techniques; used in detecting upper and hepatitis C in (Editorial) El gastrointestinal endoscopy, a cause of school aspartate aminotransferase absenteeism 555 detection of hepatitis A viral RNA in sera of patients with anisakiasis, gastroallergic; analysis in patients with allergic or acute HAV 1043 gastric symptoms 503 ratio with ALT in chronic HCV and whether it is a useful Anisakis simplex', causative agent of allergic and gastric cirrhosis predictor 386 symptoms in 22 patients 503 AST see aspartate aminotransferase antacid; for heartburn, use of 35 asymptomatic carriage; of community-based individuals, antibiotic prevalence of enteric pathogens 290 prophylaxis; complications of percutaneous endoscopic ATP see adenosine triphosphate gastrostomy (Review) 21 atrophic gastritis; histological analysis of gastritis and H. treatment; eradication of H. pylori antimicrobials in an pylori infection in patients with early gastric cancer, a urban Asian population 494 case-control study 1370 antibody autoimmune HCV; transmission of HCV in Asia: past and present disease overlaps with biliary cirrhosis and other liver perspectives E91 diseases (Editorial) 3 responses; against rectal mucosal bacteria flora in patients hepatitis; anti-neutrophil cytoplasmic antibodies in with UC 61 patients with chronic liver diseases 437 anti-coagulant therapy; haemorrhagic cerebral sinus pancreatitis; detected in the tail of the pancreas (Case thrombosis associated with, a case report on the use of Report) 461 (Case Report) 688 process; of PBS, analysis of cytokine patterns as an anti-endomysial; adult coeliac disease: prevalence and insight into the mechanisms responsible for the clinical significance 1032 (Editorial) 342 anti-envelope antibody; seroprevalence of GB virus/ HGV- autoimmunity; increases in CD95-positive CD4^ and CD8^ RNA and in high-risk populations in Taiwan 1171 T cells in peripheral blood in patients w’ith 69 anti-neutrophil cytoplasmic antibodies autonomic nervous function; in patients with essential in hepatobiliary disease (Editorial )344 hypertension, complicated with peptic ulcer 40 in patients with chronic liver disease 437 antinuclear antibodies; frequency and significance of, to Barrett's oesophagus chromatin in autoimmune hepatitis type 1 1176 K-ra5 12 mutations in, and adenocarcinomas of the antiviral drug; treatment of chronic liver diseases with oesophagus and oesophoagogastric junction 730 traditional Chinese medicine E67 understanding the molecular changes in (Editorial) 697 apoptosis BCAA see branched chain amino acids HBV X protein and putative role in hepatocarcinogenesis: Behget’s disease (Images of Interest) 1077 effects on DNA repair (Review) 357 beta-glucuronidase; human biliary, activity before and after hepatocyte; alcohol consumption induces, in patients with relief of bile duct obstruction: the major role in pigment chronic hepatitis C infection 798 gallstone formation 1071 in intestinal epithelium (Review) 109 bile duct induction of, by H. pylori 168 disorder; drug and toxin-induced (Review) 1232 reactive oxygen and mechanisms of inflammatory liver epithelial cells; effect of nucleoside analogue therapy on injury (Review) 718 duck HBV replication 304 role of, in H. py/ori-associated gastric mucosal injury malignant melanoma metastatic to the common (Case D46 Report) 1348 argatroban; effect of, on trinitrobenzene sulfonic acid- obstruction; human biliary beta-glucuronidase activity induced colitis 931 before and after relief of: the major role in pigment ascites; a boy with (Images of Interest) 957 gallstone formation 1071 Asia stones, common; temporary use of an accuflex stent chronic HBV infection in (Special Report) 1356 (Case Report) 680 perspectives on viral biliary HAV G94 complications; after orthotopic liver transplantation, hepatitis, HCV infection G90 diagnostic and therapeutic role of ERCP 654 pooled analysis of H. pylori eradication regimes in 1007 drainage; plasma human HGF in patients with 76 treatment of GORD in (Review) 230 epithelium, intrahepatic; pathophysiology of Asian patients; efficacy of a 1-week pantoprazole triple (Review) 244 therapy in eradicating H. pylori 910 lipid; excretory function is regulated by canicular Asia-Pacific region membrane fluidity 887 Subject index 1465 tract cathepsin E; clinical significance of, in the diagnosis of complications; after orthotopic liver transplantation, pancreatic ductal adenocarcinoma 1333 role of endoscopic retrograde cavography; study of the obstruction of hepatic portion of cholangiopancreatography (Editorial) 577 the inferior vena cava 202 MRI in the assessment of diffuse and focal hepatic CD44; interaction between hyaluronan and, the disease (Review) 980 development of dimethylnitrosamine-induced liver bilirubin; and bile acids may modulate their own cirrhosis 402 metabolism via regulating uridine diphosphate- celestin dilator; benign oesophageal dilatation 26 glucuronosyltransferase expression in the rat 865 cell-free extract, H. pylori', inhibition of mitogen-induced Billroth; risk of gastric cancer is not increased after partial murine lymphocyte proliferation by 1000 gastrectomy 762 chemiluminescence; activation of mucosal phospholipase D biochemical marker; of hepatic fibrogenesis in a rat model of 1138 (Editorial) 819 chemokines; impact of alcohol on the ability of Kupffer cells body mass index to produce (Review) 349 are there any sex differences in fatty liver? a study of cholangiocarcinoma; magnetic resonance angiography and glucose metabolism and body fat distribution 775 conclusions (Review) 992 determinants of basal plasma gastrin levels in the general cholangiocyte pathophysiology; better understanding of population 1267 cholangiocyte function needed to treat cholangiopathies bone mineral density, trabecular; in newly diagnosed IBD (Review) 244 patients in Korea 512 cholangitis botulinum toxin; for achalasia in children 1100 autoimmune; with features of autoimmune hepatitis, bougienage; celestin dilators and benign oesphageal successful treatment of (Case Report) 95 strictures 26 drug and toxin-induced bile duct disorders bowel syndrome, short; intestinal failure G26 (Review) 1232 branched chain amino acids cholecystokinin a balanced 5:1 carbohydrate : protein diet, for B/gastrin; quantitative measurement of mRNA coding for supplementing protein to patients with chronic liver the receptors controlling acid secretion in the ovine disease (Case Report) 1436 fundus and antrum using RT-PCR 1257 effect on composition and cytolytic activity of liver- pathophysiological role of, in humans D71 associated lymphocytes in rats 849 choledochoduodenal fistula; causes of air in bile duct prevention of proteolysis in cold-stored rat liver by (Images of Interest) 93 addition of, to the preservation solution 1199 choledocholithiasis; recurrence of biliary symptoms after Budd-Chiari syndrome endoscopic sphincterotomy in patients with gall bladder clinical features and aetiology of HCC in patients with stones 661 membranous obstruction of the inferior cholestasis; biliary excretory function is regulated by vena cava 1205 canicular membrane fluidity 887 experience with 71 patients 550 cholestatic disorders, chronic; intrahepatic biliary Burkitt’s lymphoma; association with H. pylori (Case epithelium, a primary target in (Review) 244 Report) 99 c-H-ras p21; overexpression of, is correlated with vascular endothelial growth factor expression and [‘’C]-urea breath test neovascularization in advanced gastric carcinoma 1393 determination of optimal cut-off values for 155 chromatin; frequency and significance of antibodies to, in endoscopic quantification of H. pylori infection 161 autoimmune hepatitis type I 1176 for diagnosis of H. pylori in patients with NUD 284 cirrhosis calcium channel blocker; effect of in diarrhoea-predominant alcoholic; clinical significance of HCV infection to irritable bowel syndrome 925 alcoholics with, in Korea 1282 cancer, pancreatic G13 clinical and haemodynamic aspects of hepatopulmonary Candida albicans', strains with elevated secretory proteinase syndrome in Indian patients with 412 associated with diarrhoea in children 53 effects of isosorbide-5-mononitrate administration on canicular membrane; biliary excretory function is regulated effective renal plasma flow and the renin-aldosterone by canicular membrane fluidity 887 system in cirrhotic patients 1059 carcinoma expression of hepatic thrombopoietin mRNA in primary cholangiocellular; parathyroid hormone-related peptide cultured hepatocytes 647 producing, with a marked psammoma formation (Case influence of intestinal flora on the development of fibrosis Report) 1442 in a rat model 1307 colorectal; early, flat or depressed type D66 natural history of chronic HBV infection in adults with gastrointestinal; diagnostic criteria for, in Japan and emphasis on the occurrence of HCC and E25 Western countries, proposal for a new classification non; portal-systemic encephalopathy in patients: system of gastrointestinal epithelial neoplasia G49 classification of clinical types, diagnosis and treatment use of; Sho-saiko-to, Japanese herbal medicine for (Review) 969 protection against hepatic fibrosis and D84 primary biliary; cytokine profiles in hepatic lesions 443 catabolism, of branched chain amino acids; investigation of Sho-saiko-to, Japanese herbal medicine for protection their nutritional value (Review) 706 against hepatic fibrosis and carcinoma D84 1466 Subject index stable uncomplicated; patients with, have normal detection of Listeria monocytogenes by PCR in intestinal neutrophil function 1298 mucosal biopsies from patients with IBD 1145 transjugular intrahepatic portosystemic shunt for of the oesophagus (Images of Interest) 959 intractable colonic bleeding in a patient with (Case racial difference in the prevalence of ulcerative colitis and, Report) 962 in Singapore 633 treatment of chronic HBV infection: decompensated crypt foci, aberrant; folate diminishes the occurrence of, in cirrhosis, immunosuppressed and paediatric the rat colon but does not alter global DNA methylation patients E71 status 1158 clarithromycin cut-off value; for [‘’C]-urea breath test using H. pylori efficacy of a 1-week pantoprazole triple therapy in assay 155 eradicating H. pylori in Asian patients 910 cyclo-oxygenase-2 resistance expression; relationship with K-ra5 gene mutation in and point mutations in the 23S rRNA gene in H. pylori colorectal adenomas 1277 isolates from Japan 906 inhibitor; suppresses epithelial cell kinetics and delays in H. pylori infection (Editorial) 1089 gastric wound healing in rats 752 coeliac disease cytokeratin; mortality association of enhanced CD44v6 adult; prevalence and clinical significance 1032 expression is not mediated through occult lymphatic association of human leucocyte-DR and DQ spread in stage II colorectal cancer 1028 antigens in 771 cytokine, intracellular; detection of intracellular IL-2 colitis production in peripheral T lymphocytes by flow cytometry activation of mucosal phospholipase D in a rat in pancreatobiliary malignancies 1212 model of 1138 cytolytic activity; effect of BCAA on, of liver-associated effect of argatroban on trinitrobenzene sulfonic acid- lymphocytes in rats 849 induced 931 colon cancer; risk of, in patients with hematological dendritic cell disease 1272 based, immunotherapy: potential for treatment of colonic bleeding; transjugular intrahepatic portosystemic colorectal cancer (Review) 698 shunt, in a patient with cirrhosis (Case Report) 962 decreased function of peripheral blood, in patients with colorectal HCC with HBV and HCV infection 431 adenomas; relationship between cyclo-oxygenase-2 diabetes mellitus, type II; evaluation of gut motility in, by expression and K-rus gene mutation in 1277 the radiopaque marker method 381 cancer diagnosis of a man with recurrent jaundice and abdominal common; yield from screening in people with a strong pain (Images of Interest) 454 family history of 939 diaphragmatic eventration; containing ascites, in a man dendritic cell-based cancer immunotherapy: potential presenting with haematemesis who had cirrhosis (Images for treatment of (Review) 698 of Interest) 675 flat or depressed type D66 diarrhoea mortality association of enhanced CD44v6 expression in children associated w'ith distinct strains of Candida is not mediated through occult lymphatic spread in albicans 53 stage II 1028 infective; probiotics in the treatment of IBD and NSAID with different cyclo-oxygenase inhibitory (Review) 489 profiles that prevent aberrant crypt foci formation but novel targets for the pharmacotherapy of G38 vary in acute gastrotoxicity in a rat model 1386 secretory; pancreatic vasoactive intestinal polypeptide-oma neoplasms; yield from screening in people with a strong as a cause of (Case Report) 457 family history of common colorectal cancer 939 diffuse oesophageal spasm (Images of Interest) 1341 tumour; analysis of K-ra^ codon 12 mutations and p53 disinfection overexpression in nodule-aggregating tumours 1151 of gastrointestinal endoscopes and accessories G69 complications of fundoplication (Images of reprocessing of flexible endoscopes G73 Interest) 1221 reprocessing of gastrointestinal endoscopic consensus; management of hepatic fibrogenesis; biochemical accessories G82 markers of (Editorial) 819 survey of gastrointestianl endoscope disinfection and copper; accumulation of, in the liver and hepatic injury in accessory reprocessing practices in the Asia-Pacific chronic hepatitis C 786 region G78 core gene; sequencing of, to determine codon mutations in DNA methylation; folate deficiency diminishes the chronic HCV patients 182 occurrence of aberrant crypt foci in the rat colon but does core protein, serum; relationship between histological not alter global, status 1158 prognosis of chronic HCV and 311 Doppler ultrasound; renovascular resistance assessed by, in C-reactive protein; role of, as a marker of HCC in patients patients with chronic liver disease 1424 with cirrhosis 417 double pylorus (Images of Interest) 1431 Crohn’s disease drug use, injecting; by women before and after bone mineral density in Korean patients with 512 pregnancy 175 decreased anti-Saccharomyces cerevisiae antibody titre by duct stones, pancreatic; retrieval of, using endoscopic mesalazine in patients with 1400 pancreatic sphincter balloon dilation (Case Report) 220